Exchange: NASDAQ·Updated 07:59 PM EDT
TTNP logo

TTNP Titan Pharmaceuticals, Inc. (de)

$4.61
$0.18
(3.76%)
Today
Closed $4.61
$1.30
(28.20%)
After Hours
Mkt Cap$31.9M
Vol3.36M

About TTNP

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.
48

Neutral Sentiment

How do you feel about TTNP?

Advertisement|Remove ads.